Kelli Pavlicek is a pharmacist who is specialized in Ambulatory Care in Boise, Idaho. Patients can reach her at 190 E Bannock St, Boise or contact her on 208-381-2222. Active license number of Kelli Pavlicek is P11114 for Ambulatory Care in Idaho. Kelli Pavlicek is a licensed pharmacist who has demonstrated specialized knowledge and skill in the provision of integrated, accessible health care services by pharmacists and is accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.
Complete Profile:
Kelli Pavlicek speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Kelli Pavlicek
Specialization:
Ambulatory Care
Gender:
Female
Location:
190 E Bannock St, Boise, Idaho, 83712-6241
Phone:
208-381-2222
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Kelli Pavlicek are as mentioned below.
NPI Number:
1174385447
NPI Enumeration Date:
23 Jan, 2024
NPI Last Update On:
23 Jan, 2024
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Kelli Pavlicek are as mentioned below.
Specialization
License Number
State
Status
Ambulatory Care
P11114
Idaho
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
190 E Bannock St, Boise, Idaho
Zip:
83712-6241
Phone Number:
--
Fax Number:
--
Patients can reach Kelli Pavlicek at 190 E Bannock St, Boise, Idaho or can call on phone at 208-381-2222.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.